Back

Q&A

27 August 2023 (16:09 - 16:15)
Organised by: Logo
Congress Presentation Part of: Why does an expanding data and product portfolio position lytic-free thrombectomy as the first choice for acute pulmonary embolism (PE) treatment? Acute Pulmonary Embolism Open Access ESC Congress 2023 European Society of Cardiology

3 More presentations in this session

Presentation thumbnail
Risk stratification of intermediate risk pulmonary embolism: importance of normotensive shock
Professor S. Bangalore (New York, US)
Slides Video
Presentation thumbnail
New datasets impacting the status quo of the treatment of intermediate-high pulmonary embolism patients- FLASH, PEERLESS and PEERLESS II
Professor F. Mahfoud (Basel, CH)
Slides Video
Presentation thumbnail
How does FLAME data improve the management of high-risk pulmonary embolism patients?
Doctor C. Toma (Pittsburgh, US)
Slides Video

Access the full session

Session thumbnail
Why does an expanding data and product portfolio position lytic-free thrombectomy as the first choice for acute pulmonary embolism (PE) treatment?
Video

The Event

Event poster

ESC Congress 2023

27 August 2023 16:09 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources